From the Guardian, UK.
The head of the UK’s leading cancer charity has said understanding of the disease is advancing “exponentially”, as potentially groundbreaking trials to genetically test tumours of 9,000 newly diagnosed patients begin.
Describing a “golden era” of research, Harpal Kumar, the chief executive of Cancer Research UK, said there has been “an explosion in our understanding of what cancer is, why it happens, why it doesn’t happen in some people and why it moves around the body”.
The trials backed by the Department of Health and Cancer Research UK are being launched next month in seven hospitals across Britain. Scientists believe the results could revolutionise cancer treatments.
They will aim to find out which existing drugs the cancers are susceptible to. They will also potentially pave the way for discoveries of new medicines that are personalised or targeted to the genetic makeup of an individual’s cancer and therefore far more effective